Barclays’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Barclays’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-150,000	Closed	-$770K	–	7476
2018 Q1	$770K	Buy	+150,000	New	+$903K	﹤0.01%	3521

Barclays's FOMX Position: Q1 2020 in Review

Barclays sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 39 shares.

Barclays first reported a position in FOMX in Q3 2014 and held it in 18 quarters. The position peaked at $2.43M in Q3 2016. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Barclays reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Barclays sold 39 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020.
Barclays first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2014 and held it in 18 quarters.
Barclays's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $2.43M in Q3 2016.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Barclays's 13F filing for Q1 2020, filed 13 May 2020.